PINK1 Activation and Translocation to Mitochondria-Associated Membranes Mediates Mitophagy and Protects Against Hepatic Ischemia/Reperfusion Injury
Overview
Affiliations
Hepatic ischemia/reperfusion (I/R) injury is a major concern in liver surgery settings. Mitochondria are critical targets or the origin of tissue injury, particularly I/R injury. Mitophagy, a selective form of autophagy, is a fundamental process that removes damaged or unwanted mitochondria for mitochondrial quality control, but its role in hepatic I/R remains unclear. In the present study, we investigated the role of mitophagy in hepatic I/R by focusing on PTEN-induced putative kinase 1 (PINK1). Livers from 10-week-old mice and primary hepatocytes were subjected to in vivo hepatic I/R and in vitro hypoxia-reoxygenation (H/R), respectively. Analyses of oxidative stress, immunoblotting, and ATP generation showed that hepatic I/R leads to mitochondrial damage. Dysfunctional mitochondria promoted reactive oxygen species (ROS) production and apoptosis. Hepatic I/R led to decreases in the mitochondrial proteins COX4 and TOM20 and mitochondrial DNA and increases in the autophagy-related indicators LC3 and P62, which indicates that hepatic I/R promotes mitophagy. We found that I/R also leads to endoplasmic reticulum stress, which has frequent signal communication with mitochondria through the mitochondria-associated membranes (MAMs). We showed that the mitophagy-related proteins Parkin, Beclin, optineurin were enhanced in hepatic I/R. No significant change is in PINK1 but it translocated to MAMs region to initiate mitophagy. The silencing PINK1 by shRNA in cultured primary hepatocytes reduced the level of H/R-induced mitophagy, leading to the accumulation of dysfunctional mitochondria during H/R, increased production of ROS, mitochondria-induced apoptosis, and eventually hepatocyte death. Taken together, these findings indicate that PINK1-mediated mitophagy plays a key role in mitochondrial quality control and liver cell survival during I/R.
Li L, Jin L, Tian Y, Wang J Mol Med Rep. 2025; 31(5).
PMID: 40017118 PMC: 11884227. DOI: 10.3892/mmr.2025.13476.
Li L, Zhang Z, Kuai X, Deng J, Qiu Z, Wang Z Mol Biol Rep. 2024; 51(1):776.
PMID: 38904879 DOI: 10.1007/s11033-024-09691-3.
Pan B, Ma X, Zhou S, Cheng X, Fang J, Yi Q Front Immunol. 2024; 15:1370647.
PMID: 38694511 PMC: 11061384. DOI: 10.3389/fimmu.2024.1370647.
Liu Y, Huo J, Ren K, Pan S, Liu H, Zheng Y Cell Death Discov. 2024; 10(1):148.
PMID: 38509100 PMC: 10954771. DOI: 10.1038/s41420-024-01918-3.
Mitochondrial quality control in hepatic ischemia-reperfusion injury.
Wang L, Feng Z, Ma X, Li K, Li X, Tang Y Heliyon. 2023; 9(7):e17702.
PMID: 37539120 PMC: 10395149. DOI: 10.1016/j.heliyon.2023.e17702.